Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A phase III, single-blind, randomized study to evaluate the immunogenicity and safety of Fluarix® (GSK Biologicals) compared with Fluzone® (Aventis Pasteur/Sanofi) administered intramuscularly in children (6 months and older)
Influenza Vaccine (Split Virion, Inactivated)
104858
NCT00383123
Influenza
Phase 3
 
March 2014

Powered by ideaPoint, Inc.